Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001144204-17-038499

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CANNON MICHAEL D Director 2017-07-24 Grant or award · Option to purchase common stock +15,000 35,000 D: show line 1 in the form
Loading xslF345X03/v471463_4.xml…